|
Acti
Cyclase - Related Research* Coleus forskholii is an interesting and
exciting herb to work with both clinically and experimentally.
Interesting because it is one of the few plants for which the
biochemical mechanism of action has been well researched, and exciting
because of its ability to stimulate the enzyme Adenylate Cyclase (AC),
the biochemist.s dream enzyme. Thus, the active ingredient Forskolin
produces a myriad of biological effects. |
Chemistry
Forskolin, obtained from the root of the extract of Coleus forskholii,
is an oily di-labdane terpene. Forskolin has received much attention due to
its ability to stimulate a membrane bound enzyme . Adenylate Cyclase
(AC). Prior to forskolin.s discovery, there was no known activator of this
enzyme. Adenylate Cyclase (AC) is an enzyme-system-complex, with
various activating catalytic units and sub-units embedded in the membrane
bi-layers of numerous tissues including the myocardium, bronchioles,
arteries, kidneys, etc. AC has two polar sub-units . the catalytic C unit
and the nucleotide regulatory sub-unit N. Forskolin directly stimulates the
C subunit, resulting in stimulation of cyclic adenosine mono phosphate (cAMP),
which in turn activates and elicits a cascade of enzymatic functions. cAMP
is an important second messenger, one of the most vital regulatory
compounds in the cell.
Forskolin is a remarkably targeted botanical with unique and extensive
pharmacological properties for cellular regulation, biological response
modification and the fine tuning numerous enzymatic reactions.
Pharmacology - Cardiology
(1) Increases Contractility.
Forskolin is a potent inotropic agent. Stimulation of cAMP production
increases the contractility of the myocardium. Beta adrenergic agonists are
potent pharmacologic agents in this regard and have been used
therapeutically in the treatment of heart failure. However, such compounds
have a major disadvantage that limits their long-term use. Continuous
exposure to beta-agonists renders the myocardium sub-sensitive by reducing
beta-receptor density and/or receptor-cyclase coupling. Both of these
sub-sensitivity phenomena are apparently regulated through the N sub-unit of
AC. Forskolin, however, acts primarily via the C-sub-unit and does not
demonstrate the subsensitive phenomena or beta-receptor down-regulation.
Indeed forskolin exhibits positive inotropic and chronotropic
characteristics, as seen in the guinea pig, sheep, rat, pig, rabbit and
humans.
2) Inhibition of Platelet Aggregation.
Inhibition of platelet aggregation has beneficial effects on morbidity and
mortality. Forskolin stimulates platelet AC, resulting in increased cAMP and
a corresponding decrease in platelet aggregation.
3) Inhibits Thrombosis.
Forskolin produces deaggregation of aggregated human platelets
in-vitro and may offer an important prophylactic treatment in preventing
thrombosis.
4) Hypertension.
Forskolin was shown to be a potent vasodilator in a dose-dependent manner.
Forskolin induced vasodilation similar to isoproterenol, a potent
beta-agonist. Forskolin significantly decreased preload and
afterload and improved left ventricular function.
Allergic Conditions
(1) Asthma
Low cAMP levels have an association with high incidence of allergic
reactions, including eczema, psoriasis, and asthma. Forskolin
elicits anti-asthmatic activity via the following:
(2) Relaxes bronchial smooth muscle by increasing cAMP (an effect
comparable with a prescription drug fenoterol, though the effect was not as
long lasting).
(3) Inhibits Platelet Activating Factor (PAF) by competitive
inhibition. PAF has the following properties: increased bronchial
permeability and smooth muscle contraction. A 40% decrease in PAF binding
was observed after pretreatment with forskolin. This antagonistic action on
PAF by forskolin is not via the stimulation of cAMP, but by another direct
stimulation mechanism.
(4) Psoriasis. In psoriasis, cyclic guanine monophosphate (cGMP),
another secondary messenger and regulator of cellular action, is greatly
increased compared to cAMP. By stimulating cAMP levels, the cGMP/cAMP ratios
are reduced to normal levels. High cGMP are associated with a high rate of
cellular division, a characteristic of psoriasis.
Other Biological Actions
Glaucoma - Topical preparation of forskolin greatly reduced
intraocular pressure without inducing miosis.
Hypothyroidism - Increases thyroid hormone production and release.
Anti-Inflammatory - PAF is a potent inflammatory agent, activating
neutrophils and increasing vascular permeability. Forskolin is a potent
inhibitor of PAF via a unique non-cAMP mechanism.
Antispasmodic - Forskolin is a potent relaxer of smooth muscles.
Useful in angina, intestinal cramps, difficulty in bladder emptying, etc.
Weight loss - Forskolin, like B-agonists, stimulates lipolysis via increased
cAMP levels, an effect possible through increased thermogenesis and improved
thyroid activity.
Salivation - Increases saliva output (useful in treating conditions
associated with dry mouth).
Forksolin should be produced as a full-spectrum,
optimally-standardized product verified by HPLC. 4% Forskolin content is the
maximal amount extractable without compromising the quality and exclusion of
other beneficial compounds. Personal communication with one of the original
(and leading) researchers at Hoechst Pharmaceutical, Bombay, India (where
the original work was done) has revealed that an extract above 4% results in
a less effective product due to the loss of other beneficial
molecules. Chemical synthesis has been utilized to produce higher forskolin
content, but without achieving similar therapeutic efficiency to a 4%
extract.
References:
i. Burka, J.F. (1986) In .Forskolin: Its Chemical, Biological and Medical
Potential. (R.H. Rupp, N de Souza and A.N. Dohadwalla, eds.), pp127-136.
Hoechst India Ltd.
ii. Ammon. HPT and Muller AB: (1985) Forskolin: .From Ayurveric remedy to a
modern agent.. Planta Medica; 51: 474-7.
iii. De Souza N.J. (1986) .Forskolin- An example of Innovative Drug Research
and Natural Products. in A.F. Harms (ED.), Innovative approach in drug
research, Elsevier Science Publishers, Amsterdam, pp.191-207.
iv. Daly JW. .Forskolin, adenylate cyclase, and cell physiology: an
overview.. Adv Cyclic Nucleotide Protein Phosphorylation Res 1984;17:81-9.
v. Seamon KB, Daly JW. .Forskolin: a unique diterpene activator of cyclic
AMP-generating systems.. J Cyclic Nucleotide Res 1981;7(4):201-24.
vi. Caprioli J, Sears M. .Forskolin lowers intraocular pressure in rabbits,
monkeys, and man.. Lancet 1983 Apr 30;1(8331):958-60.
vii. Buschmans E, Hearse DJ, Manning AS. .Forskolin: effects on cyclic AMP
and contractile function in the isolated rat and guinea pig heart.. Can J
Cardiol. 1985 Nov-Dec;1(6):385-94.
viii. Kreider R, Henderson S, Magu B, Rasmussen C, Lancaster S, Kerksick C,
Smith P, Melton C, Cowan P, Greenwood M, Earnest C, Almada A. .Effects of
Coleus Forskohlii Supplementation on Body Compostion and Markers of Health
in Sedentary Overweight Females.. FASEB J. 2002; 16 Suppl: 59 (LB305).